Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants
Mingteng International Corporation, a Cayman holding company making automotive casting molds in Wuxi, China, disclosed in its six-month period report to June 30, 2026 a June 9, 2026 registered direct offering. It agreed to sell 501,834 Class A shares at $2.00 each, plus pre-funded warrants for up to 629,170 shares, to institutional investors. The company also reported shareholder approval on May 29, 2026 of higher Class B voting rights and a par value reduction. It is not a pharma or biotech business.
13 Nov 2026 · Mingteng International Corp Inc. MTEN · Company news
Company's press release (SEC filing): Mingteng International Corp Inc. ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.
More FinancingAll →
Financing
IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M
13 Nov 2026 · IM Cannabis Corp. IMCC · Company news
Financing
Femasys Q3 2026: $30M private placement closed; U.S. sales flat, total sales fall 44.5% to $404,597
13 Nov 2026 · Femasys Inc FEMY · Company news
Financing
Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities
13 Nov 2026 · Organigram Global Inc. OGI · Company news
Financing
Windward Bio prices Nasdaq IPO of 10.3 million shares at $17, targeting $225 million in gross proceeds
12 Nov 2026 · Windward Bio Group AG · Company news
Financing
Lichen International prices $3.5M registered direct offering of units with warrants on Nasdaq
12 Nov 2026 · Lichen International Ltd LICN · Company news
Financing
Tenon Medical Q3 2026 revenue up 22% to $1.4M; convertible notes repaid after $15.6M raised
12 Nov 2026 · Tenon Medical, Inc. TNON · Company news